SUMMARY OF HEPATITIS Flashcards

1
Q

Serum hepatitis

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Post transfusion hepatitis

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Non A and Non B hepatitis

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Picornaviridae ssRNA

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hepadnaviridae dsDNA

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Flaviviridae ssRNA

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Deta virus; requires HBV for replication

A

HDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Caliciviridae ssRNA

A

HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

15-45 days

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

45-160 days

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

15-150 days

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

30-60 days

A

HDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

15-60 days

A

HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fecal-oral

A

HAV
HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sex, blood transfusion, sharing of needles, transplacental saliva, breastmilk

A

HBV
HDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sex, blood transfusion, sharing of needles, transplacental saliva, breastmilk, hemodialysis

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Infectious hepatitis

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

• Present in stool and plasma for an average of 18 days after the clinical of disease

A

HAV RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

• Indicates recent infection

A

Anti-HAV IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

• Develops 2-3 weeks after ingestion and persists up to 3-6 mos

A

Anti-HAV IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

• Develops 1-2 weeks after IgM

A

Anti-HAV IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

• Present for life

A

Anti-HAV IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

• Active hepatitis B

A

HbsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

• Acute infection and infectivity

A

HbsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

• General marker of infection

A

HbsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

• Active hepatitis B with high degree with increased risk of infectivity

A

HBeAg

27
Q

• Circulating for HbcAg

A

HBeAg

28
Q

• Current or recent and hepatocellular acute hepatitis B

A

Anti-HBc IgM

29
Q

• Important in diagnosing during window period.

A

Anti-HBc IgM

30
Q

• Current or past hepatitis B

A

Total anti-HBc

31
Q

• Recovery from hepatitis B

A

Anti-HBe

32
Q

• Immunity to hepatitis B or past infection

A

Anti-HBs

33
Q

• Acute, atypical, or occult hepatitis B

A

HBV DNA

34
Q

• Viral load may be used to monitor effectiveness of therapy

A

HBV DNA

35
Q

• Generally used to diagnose Hepatitis C infection.

A

Anti-HCV

36
Q

• 4 weeks after infection (not reliable)

A

Anti-HCV

37
Q

• Used in monitoring he response to antiviral therapy

A

HCV-RNA

38
Q

• Diagnosis in the acute phase

A

HCV-RNA

39
Q

• Identification of HCV genotype

A

HCV-RNA

40
Q

increase risk infectivity

Indicated that virus has high degree of infectivity

A

Envelope antigen

41
Q

Progression to chronic state

A

HBV
HCV
HDV

42
Q

No Progression to chronic state

A

HAV

HEV

43
Q

Acute, self limiting

A

HAV

HEV

44
Q

Most: acute

A

HBV

45
Q

Others: Chronic (10%-90%), cirrhosis, risk of Ca

A

HBV

46
Q

80-85% will have a chronic disease

A

HCV

47
Q

15-20% spontaneous resolution

A

HCV

48
Q

Super infection/ coninfection with Hepatitis B

A

HDV

49
Q

Acute selflimiting

A

HAV

HEV

50
Q

Fluminant liver failure in pregnant women

A

HEV

51
Q

(+) Early infection

A

Anti-HBc IgM
Total Anti-HBc
HBeAg
HBV DNA

52
Q

(-) Early infection

A

Anti-HBs

Anti-HBe

53
Q

(+) Window

A

Anti-HBc IgM
Total Anti-HBc
HBV DNA

54
Q

(-) Window

A

HBeAg

HBsAg

Anti-HBs

Anti-HBe

55
Q

(-) Convalescent

A
56
Q

(+) Convalescent

A
57
Q

(+/-) Convalescent

A
58
Q

(-/+) Convalescent

A
59
Q

(+/-) Chronic

A
60
Q

(-/+) Chronic

A
61
Q

(+) Chronic

A
62
Q

(-) Chronic

A
63
Q

(-) Post vaccination

A
64
Q

(+) Post vaccination

A